L. Tybring
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 11
- Drug-Induced Adverse Reactions 4
-
- Phenothiazines and Benzothiazines Synthesis and Activities 5
- Cancer therapeutics and mechanisms 2
- Co-authors
- K Roholt (5 shared papers)W. O. Godtfredsen (5 shared papers)F Lund (2 shared papers)W. von Daehne (3 shared papers)Hans J. Petersen (1 shared paper)S. Vangedal (2 shared papers)F. Güttler (1 shared paper)A. Birch‐Andersen (1 shared paper)
In The Last Decade
L. Tybring
24 papers receiving 767 citations
Peers
Comparison fields: 5 of 93
- Molecular Medicine 238
- Pharmacology 392
- Infectious Diseases 174
- Clinical Biochemistry 60
- Applied Microbiology and Biotechnology 14
Countries citing papers authored by L. Tybring
This map shows the geographic impact of L. Tybring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Tybring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Tybring more than expected).
Fields of papers citing papers by L. Tybring
This network shows the impact of papers produced by L. Tybring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Tybring. The network helps show where L. Tybring may publish in the future.
Co-authors
The 16 scholars most cited alongside L. Tybring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1962 | 164 | |
| 2 | 1972 | 161 | |
| 3 | 1962 | 124 | |
| 4 | 1970 | 112 | |
| 5 | 1975 | 87 | |
| 6 | Pivampicillin, a new orally active ampicillin ester. | 1970 | 49 |
| 7 | 1975 | 46 | |
| 8 | 1966 | 38 | |
| 9 | 1973 | 30 | |
| 10 | 1971 | 27 | |
| 11 | 1975 | 16 | |
| 12 | 1969 | 13 | |
| 13 | 1974 | 10 | |
| 14 | 1962 | 9 | |
| 15 | Transformations of fusidic acid and the relationship between structure and antibacterial activity. | 1965 | 6 |
| 16 | 1977 | 5 | |
| 17 | 1979 | 4 | |
| 18 | [Fucidin, a new antibiotic for peroral therapy]. | 1962 | 4 |
| 19 | 1957 | 3 | |
| 20 | 1967 | 3 |
About L. Tybring
L. Tybring is a scholar working on Pharmacology, Molecular Biology, Molecular Medicine, Infectious Diseases and Organic Chemistry, having authored 24 papers that have together received 917 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Drug-Induced Adverse Reactions (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Cancer therapeutics and mechanisms (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Molecular Medicine (238 citations), Pharmacology (392 citations), Infectious Diseases (174 citations), Clinical Biochemistry (60 citations) and Applied Microbiology and Biotechnology (14 citations). L. Tybring has collaborated with scholars based in Denmark and Australia. Frequent co-authors include K Roholt, W. O. Godtfredsen, F Lund, W. von Daehne, Hans J. Petersen, S. Vangedal, F. Güttler, A. Birch‐Andersen, Jens Blom and R Vejlşgaard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Journal of Antimicrobial Chemotherapy, The Journal of Antibiotics and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.